{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-062503","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.951315+00:00","generated_at":"2026-06-01T21:33:22.614116+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bicycle Therapeutics shareholders approve all 11 proposals at 2024 AGM","bullets":["Directors Kevin Lee (36.4M for) and Jose-Carlos Gutierrez-Ramos (35.0M for) re-elected.","Advisory vote on executive compensation passed with 36.2M for, 1.2M against.","Ratification of PwC as US and UK auditors approved with ~37.4M for each.","Share allotment authorization and pre-emption rights disapplication passed with >32M for each.","New articles of association adopted with 37.4M for, 15,138 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-062503","json":"https://secwatch.observer/filing/0001104659-24-062503.json","markdown":"https://secwatch.observer/filing/0001104659-24-062503.md","text":"https://secwatch.observer/filing/0001104659-24-062503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/tm2414682d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T21:33:22.614116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07798c60cdcde08718df86944911e954158040be","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2023. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"40bec102583ed2d2289a3e5c0c05d3d1fdfcc922","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 11 – To adopt the new articles of association in substitution for, and to the exclusion of, the Company’s existing articles of association. For Against Vote Withheld/Abstain 37,371,711 15,138 11,258","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"419297d81db825634cb37b3c06270d7f6b083dda","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2024. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors (the “Board”) to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,455 14,150 7,502","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"558cc14f370e2a956ff95ac90ef9c651c681c1ae","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 36,186,115 1,202,477 9,515","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"9713dd0068a7cc44dcf2a51866ae6535e1cb5ad7","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 10 – To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. For Against Vote Withheld/Abstain 32,350,797 4,154,715 892,595","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"ad85b1ff154b6fb107385b755751233d10c2cb50","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 9 – To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. For Against Vote Withheld/Abstain 33,241,556 4,146,578 9,973","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"d2747917411399b0549191d9ab03c1cfc2a2a056","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,526 14,076 7,505","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"d769b58fb372be62bc9fb99c5e324d251812a4ea","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Kevin Lee. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 1 – To re-elect as a director Kevin Lee. For Against Vote Withheld/Abstain 36,413,260 977,286 7,561","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"df0eb18b925049511adb3741c0489a75615b13e1","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2023. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,494,043 896,166 7,898","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"e7ad26cba3d0c1c5fdc18b7c75b7a5cf6f273f85","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Jose-Carlos Gutierrez-Ramos. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 2 – To re-elect as a director Jose-Carlos Gutierrez-Ramos. For Against Vote Withheld/Abstain 35,019,069 2,371,385 7,653","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9},{"claim_id":"f96cd3195df0281cd26a4d3b182fb848e2569bfe","claim":"BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2024-05-16 meeting.","evidence_excerpt":"Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 37,376,531 14,071 7,505","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001683168-26-004438","ticker":"APCX","company_name":"AppTech Payments Corp.","filed_at":"2026-06-02T12:30:16+00:00","headline":"AppTech shareholders elect directors, approve say-on-pay and equity plan at annual meeting","event_type":"other","sec_items":["5.07"],"materiality_score":0.3,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-004438","json":"https://secwatch.observer/filing/0001683168-26-004438.json","markdown":"https://secwatch.observer/filing/0001683168-26-004438.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070050/000168316826004438/0001683168-26-004438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070050/000168316826004438/apptech_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"The appointment of dbbmckennon, LLC as the Company’s independent registered public accounting firm for fiscal year 2026 was ratified by the shareholders: Votes For Against Abstain Broker Non-Votes 25,837,544 78,756 1,648,545 -","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1070050/000168316826004438/0001683168-26-004438-index.htm"}},{"accession":"0001104659-26-069168","ticker":"JHG","company_name":"JANUS HENDERSON GROUP PLC","filed_at":"2026-06-02T10:07:33+00:00","headline":"Janus Henderson shareholders approve all proposals at 2026 AGM","event_type":"other","sec_items":["5.07"],"materiality_score":0.25,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069168","json":"https://secwatch.observer/filing/0001104659-26-069168.json","markdown":"https://secwatch.observer/filing/0001104659-26-069168.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274173/000110465926069168/0001104659-26-069168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274173/000110465926069168/tm2616586d1_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"shareholders ratified the reappointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2026 and authorized the Directors to determine their remuneration (Proposal 5).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1274173/000110465926069168/0001104659-26-069168-index.htm"}},{"accession":"0001193125-26-251779","ticker":"MERC","company_name":"MERCER INTERNATIONAL INC.","filed_at":"2026-06-01T21:26:15+00:00","headline":"Mercer International shareholders elect all director nominees, approve say-on-pay, ratify PwC","event_type":"other","sec_items":["5.07"],"materiality_score":0.0,"calibrated_materiality_score":0.0,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251779","json":"https://secwatch.observer/filing/0001193125-26-251779.json","markdown":"https://secwatch.observer/filing/0001193125-26-251779.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1333274/000119312526251779/0001193125-26-251779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1333274/000119312526251779/d118466d8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm. The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2026 was ratified, and the voting results are set forth below: For Against Abstentions Broker Non-Votes 51,015,419 175,603 524,952 0","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1333274/000119312526251779/0001193125-26-251779-index.htm"}},{"accession":"0001403475-26-000031","ticker":"BMRC","company_name":"Bank of Marin Bancorp","filed_at":"2026-06-01T21:11:54+00:00","headline":"Bank of Marin shareholders elect all 10 directors, approve say-on-pay, ratify auditor","event_type":"other","sec_items":["5.07","8.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001403475-26-000031","json":"https://secwatch.observer/filing/0001403475-26-000031.json","markdown":"https://secwatch.observer/filing/0001403475-26-000031.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1403475/000140347526000031/0001403475-26-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1403475/000140347526000031/bmrc-20260527.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"To elect ten members of the Board of Directors to serve until the next Annual Meeting of Shareholders or until their successors are duly elected and qualified. Number of Votes For Withheld Non-Vote Nicolas C. Anderson 10,405,859 784,544 1,932,287 Russell A. Colombo 7,509,925 3,680,478 1,932,287 Charles D. Fite 10,810,421 379,982 1,932,287 Cigdem F. Gencer 10,818,514 371,888 1,932,287 James C. Hale 10,912,128 278,274 1,932,287 Kevin R. Kennedy 10,974,404 215,998 1,932,287 Timothy D. Myers 10,691,557 498,846 1,932,287 Joel Sklar, MD 10,985,406 204,997 1,932,287 Brian M. Sobel 10,859,501 330,902 1,932,287 Secil T. Watson 10,256,810 933,593 1,932,287","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1403475/000140347526000031/0001403475-26-000031-index.htm"}},{"accession":"0001104659-26-068996","ticker":"XBP","company_name":"XBP Global Holdings, Inc.","filed_at":"2026-06-01T21:00:49+00:00","headline":"XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068996","json":"https://secwatch.observer/filing/0001104659-26-068996.json","markdown":"https://secwatch.observer/filing/0001104659-26-068996.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/0001104659-26-068996-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/tm2616124d2_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"· Proposal 3 — To consider and vote upon a proposal to approve, on an advisory (non-binding) basis, the compensation of our named executive officers (the “say-on-pay vote”): Votes For Votes Against Votes Abstained Broker Non-Votes 8,208,462 1,323,885 1,011 577,920","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/0001104659-26-068996-index.htm"}},{"accession":"0001733998-26-000111","ticker":"NWN","company_name":"Northwest Natural Holding Co","filed_at":"2026-06-01T20:21:37+00:00","headline":"NWN shareholders elect three directors, approve say-on-pay, ratify PwC","event_type":"other","sec_items":["5.07"],"materiality_score":0.15,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001733998-26-000111","json":"https://secwatch.observer/filing/0001733998-26-000111.json","markdown":"https://secwatch.observer/filing/0001733998-26-000111.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733998/000173399826000111/0001733998-26-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733998/000173399826000111/nwn-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 was ratified. FOR 35,733,652 AGAINST 1,056,147 ABSTAIN 112,887 BROKER NON-VOTES N/A","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1733998/000173399826000111/0001733998-26-000111-index.htm"}},{"accession":"0000950142-26-001571","ticker":"GTX","company_name":"Garrett Motion Inc.","filed_at":"2026-06-01T20:16:15+00:00","headline":"Garrett Motion shareholders elect all eight directors and ratify Deloitte as auditor","event_type":"other","sec_items":["5.07"],"materiality_score":0.05,"calibrated_materiality_score":0.05,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-26-001571","json":"https://secwatch.observer/filing/0000950142-26-001571.json","markdown":"https://secwatch.observer/filing/0000950142-26-001571.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735707/000095014226001571/0000950142-26-001571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735707/000095014226001571/eh260786002_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"Item 2 - Ratification of the appointment of Deloitte SA as the Company's independent registered public accounting firm for the year ending December 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1735707/000095014226001571/0000950142-26-001571-index.htm"}},{"accession":"0001104659-26-068932","ticker":"CLAR","company_name":"Clarus Corp","filed_at":"2026-06-01T20:15:32+00:00","headline":"Clarus shareholders elect all five director nominees, approve say-on-pay and auditor ratification","event_type":"other","sec_items":["5.07"],"materiality_score":0.1,"calibrated_materiality_score":0.1,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068932","json":"https://secwatch.observer/filing/0001104659-26-068932.json","markdown":"https://secwatch.observer/filing/0001104659-26-068932.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/913277/000110465926068932/0001104659-26-068932-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/913277/000110465926068932/tm2616044d1_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm","comparable_excerpt":"Proposal 1 – To elect five directors to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Name Votes For Votes Withheld Broker Non-Votes Warren B. Kanders 22,373,079 5,085,245 5,086,329 Nicholas Sokolow 20,395,026 7,063,298 5,086,329 Susan Ottmann 22,314,213 5,144,111 5,086,329 Roger Werner 21,940,144 5,518,180 5,086,329 Mark M. Besca 22,037,878 5,420,446 5,086,329","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/913277/000110465926068932/0001104659-26-068932-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}